Patients without comorbidities (0 on the Elixhauser Comorbidity Index and the RDCI score and without heart disease, diabetes, or gastrointestinal bleeds) had lower odds of receiving DMARDs with hepatitis B screening. This evidence concerns the gene PPIB and Hepatitis.